Basic Information
Basic information for LINC01876-202-31aa
Peptide Name LINC01876-202-31aa
Genome Position chr2:156024505-156024597[-]
Species Human
Peptide Sequence MEEDTWKNQGRVKKILQKIGEDFHHKVQAKA
Peptide Length 31
Unique No (LINC01876-203-31aa,LINC01876-204-31aa,LINC01876-205-31aa,LINC01876-206-31aa,LINC01876-208-31aa,LINC01876-210-31aa)
Grand Average of Hydropathicity -1.2484
Relative Molecular Mass 4233.73
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000226383;LINC01876
Transcript ID/Name ENST00000448255;LINC01876-202
Transcript Length 797
Coding Ability 0.6386
DNA Sequence Corresponding to Peptide ATGGAAGAAGATACTTGGAAAAATCAGGGAAGAGTGAAGAAGATACTTCAAAAAATCGGGGAAGATTTTCATCATAAGGTCCAAGCAAAGGCA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :